News

STORM Therapeutics appoints CEO and Chairman

STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies from RNA epigenetics, moved to the next stage of its development with the appointment of Keith Blundy as...

RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 2021 Dates To be Confirmed

Find out more